Skip to main content
. 2011 Aug 22;1:17. doi: 10.1186/2191-219X-1-17

Figure 5.

Figure 5

PS-annexin V imaging (North American Scientific 2020 - Phase II-III Clinical Trial - Antwerp 2003). A patient with a left para-hilar NSCLC on pre-chemotherapy CT (upper right: simple white arrow) who presented with 99mTc-HYNIC-annexin V uptake post-chemotherapy in the primary lung tumour (upper left: simple white arrow) and the right upper humerus bone metastasis (upper left: yellow arrow). After the first course of chemotherapy, diagnostic CTs showed a decrease in the primary lung tumour greatest diameter, which was consistent with an apoptotic tumour response to chemotherapy (lower left and lower right: simple white arrows). Upper left (A): post-chemotherapy 99mTc-HYNIC-annexin V scan; upper right (B) and lower left (C): pre-chemotherapy diagnostic CTs; lower right (D): post-chemotherapy diagnostic CT.